BioSpace News Archive

Business

AMAG Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update

AMAG Pharmaceuticals, Inc. reported unaudited consolidated financial results for the first quarter ended March 31, 2020.

May 11, 2020
·
12 min read
Business

Recro Reports First Quarter 2020 Financial Results and Provides Update on COVID-19 Response and Impact

Recro Pharma, Inc., a leading contract development and manufacturing organization, with integrated solutions for the development, formulation, regulatory support, manufacturing and packaging of oral solid dose drug products, reported financial results for the three months ended March 31, 2020.

May 11, 2020
·
10 min read
Business

Applied Therapeutics Reports First Quarter 2020 Financial Results

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, reported financial results for the first quarter ended March 31, 2020.

May 11, 2020
·
10 min read
Business

Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases

Agreement leverages Sarepta’s leadership in gene therapy for neuromuscular and cardiovascular diseases and Dyno’s CapsidMap artificial intelligence platform to design AAV vectors

May 11, 2020
·
8 min read
Deals

Protagonist Therapeutics, Inc. Announces Proposed Underwritten Public Offering of Common Stock - May 11, 2020

Protagonist Therapeutics, Inc., a clinical stage biopharmaceutical company, announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock.

May 11, 2020
·
3 min read
Business

Menlo Reports First Quarter 2020 Financial Results and Provides Business Update

Menlo Therapeutics Inc., a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, announced financial results for the first quarter ended March 31, 2020 and provided a corporate update.

May 11, 2020
·
9 min read
BioMidwest

Bio-Techne Announces Release of GMP Cloudz™ Human T Cell Activation Kit

Bio-Techne Corporation announced the release of the GMP Cloudz™ Human T Cell Activation Kit.

May 11, 2020
·
1 min read
BioMidwest

Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration

Regeneron Genetics Center will sequence 450,000 informed and consented patients

May 11, 2020
·
11 min read
Alkermes Announces Expansion of Patient Services and Provider Network to Support Uninterrupted Access to ARISTADA® and VIVITROL® During COVID-19 Crisis

Retail Pharmacies, Including 900 Albertsons Locations, Added to the Provider Locator to Provide Injections of ARISTADA and VIVITROL; Additional Programs In Place to Deliver Support and Financial Assistance

May 11, 2020
·
20 min read
Business

AbSci Appoints Greg Schiffman As Chief Financial Officer

AbSci, the Protein Printing™ company, is pleased to announce the appointment of Greg Schiffman, CPA as Chief Financial Officer.

May 11, 2020
·
2 min read